Experience Life, Needs and Expectations of Families of Older Polyhandiccaped Persons (PolyAge)

January 25, 2024 updated by: Assistance Publique Hopitaux De Marseille
The general objective of PolyAGE is to explore the life experience of familial caregivers of aging persons with polyhandicap (>= 35 years). The investigators will question parents (objective 1) and siblings (objective 2) about the experiences, the social representations, the needs and the expectations, as well as the mechanisms associated with their choices about their children with polyhandicap. The objective 3 is to co-analyze parents' and siblings' experiences regarding the aging of their relatives with polyhandicap.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Context Polyhandicap as a chronic complex disability condition, lead to a combination of profound intellectual disability and serious motor deficit, resulting in the extreme restriction of autonomy and communication. Due to the improvement of preventive actions and supportive care, the life expectancy of these persons is increased In order to assess the issues associated with the aging of people with polyhandicap (an emerging and underexplored phenomenon), life experiences, social representations, specific needs and expectations of familial caregivers (parents and siblings) need to be explored. It is essential to better understand these phenomenon in order to better support and assist these families. The PolyAGE project relies on an interdisciplinary approach, based on social and human sciences (social psychology of health) and public health. PolyAGE is based on a solid network including engaged and volunteer actors.

Objectives The general objective of PolyAGE is to explore the life experience of familial caregivers of aging persons with polyhandicap (>= 35 years). The investigators will question parents (objective 1) and siblings (objective 2) about the experiences, the social representations, the needs and the expectations, as well as the mechanisms associated with their choices about their children with polyhandicap. The objective 3 is to co-analyze parents' and siblings' experiences regarding the aging of their relatives with polyhandicap.

Methods

PolyAGE relies on the EVAL-PLH cohort, initiated in 2015, including persons with polyhandicap, familial and institutional caregivers. Eight teams are involved in PolyAGE: 2 specialized reeducation centers (Hendaye et San Salvadour), the J. Bost Foundation, the Groupe Polyhandicap France (family association), 3 university teams (CeReSS and LPS of Aix Marseille university and SantESiH of Montpellier university), 1 epidemiology team (AP-HM).The investigators propose a pluri-methodological mixt approach combining quantitative and qualitative approaches in a socio-contextual and comprehensive perspective:

  1. Quantitative approach:

    • Evaluations using standardized self-reported questionnaires: quality of life, coping, emotional intelligence, burden.
    • Parents: data already available (EVAL-PLH cohort: 2 evaluation times 20151-6 and 2020-21).
    • Siblings: data to be collected (phone, mail).
  2. Qualitative approach:

    • Evaluations based on interviews (parents and siblings; 1 confounding factor: participant's sex);
    • Combination of interviews content and interpretative phenomenological analysis.
  3. Methodological triangulation:

    • Crossing and confrontation of quantitative and qualitative findings. Perspectives
    • Improvement of knowledge and identification of the specific needs/expectations of family caregivers of aging persons with polyhandicap.
    • Understanding the underlying reasons behind the choices made by families in terms of support for aging persons with polyhandicap in order to support the transitions related to the joint aging of persons with polyhandicap and their relatives.
    • Better supporting families in the aging transition (health professionals, health-decision makers).

Study Type

Observational

Enrollment (Estimated)

82

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Emilie GARRIDO-PRADALIE, Study direc
  • Phone Number: 0491382747
  • Email: drci@ap-hm.fr

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Persons with severe polyhandicap aged 35 and over. Severe polyhandicap was defined according to the following criteria:

  • presence of a brain lesion that occurred before the age of 3,
  • IQ below 40 or not assessable,
  • motor handicap: para/tetraparesis or hemiparesis,
  • Gross Motor Function Classification System score of III, IV or V,
  • Functional Independence Measure score below 55

Description

Inclusion Criteria:

  • Mother or father (>=18 years) of a with severe polyhandicap aged 35 and over at the time of inclusion
  • Person (>=18 years) having at least one parent in common with a person with a severe polyhandicap aged 35 and over at the time of inclusion
  • Person agreeing to participate after having been informed of the study's objectives and procedures

Exclusion Criteria:

  • Parents and siblings whose inclusion criteria concerning the Persons with severe polyhandicap are not fulfilled
  • Parents and siblings who refuse to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experiences of parents of aging persons with polyhandicap
Time Frame: 30 minutes to fill in the booklet and about 60 minutes for the interview
Evaluations using standardized self-reported questionnaire: quality of life and evaluation based on interviews to be conducted during the present study
30 minutes to fill in the booklet and about 60 minutes for the interview

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experiences of siblings of aging persons with polyhandicap
Time Frame: 30 minutes to fill in the booklet and about 60 minutes for the interview
Evaluations using standardized self-reported questionnaire: quality of life and evaluations based on interviews to be conducted during the present study
30 minutes to fill in the booklet and about 60 minutes for the interview
Crossing and confrontation of quantitative and qualitative findings
Time Frame: 2 months
A cross of quantitative evaluation (questionnaire) and qualitative evaluation (interviews) by methodological triangulation analysis
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: karine baumstarck, PI, Assistance Publique des Hôpitaux de Marseille (AP-HM)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2024

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

January 3, 2024

First Submitted That Met QC Criteria

January 15, 2024

First Posted (Actual)

January 24, 2024

Study Record Updates

Last Update Posted (Actual)

January 26, 2024

Last Update Submitted That Met QC Criteria

January 25, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RCAPHM23_0212

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Polyhandicap

3
Subscribe